Stem Cell Therapeutics Markets

Table of Contents

CHAPTER ONE: EXECUTIVE SUMMARY

• Recent Developments
• Introduction
• Current Stem Cell Therapies
• Developmental Stem Cell Therapies
• Issues in Stem Cell Research
• Stem Cell Forecasts
• Market Forecast
• The Promise of Stem Cells in Medical Treatment
• Types of Stem Cells
• Embryonic Stem Cells
• Important Developments in ES Cell Research
• Adult Stem Cells
• Important Developments
• Scope and Methodology

CHAPTER TWO: CURRENT STEM CELL THERAPIES

• Cancer
• Leukemia
• Gene Therapy
• Multiple Myeloma
• Non-Hodgkin' s Lymphoma Noncancerous Diseases
  • Aplastic Anemia
  • Immunodeficiency
  • Lupus
  • Sickle Cell Disease
  • Other Conditions

CHAPTER THREE: DEVELOPMENTAL STEM CELL THERAPIES

• Alzheimer' s Disease
• Arthritis
• Burns
• Cancer
• Cardiovascular Conditions
• Critical Limb Ischemia
• Crohn' s Disease
• Diabetes
• Incontinence
• Infertility
• Liver Failure
• Lung Disease
• Multiple Sclerosis
• Orthopedics
• Osteoporosis
• Parkinson' s Disease
• Sickle Cell Disease

CHAPTER FOUR: STEM CELL MARKET FORECASTS

• Best Case
  • Forecasts By Disease Area
  • Alzheimer' s Disease
  • Arthritis
  • Burns
  • Cancer,
  • Cardiovascular Conditions
  • Critical Limb Ischemia
  • Crohn' s Disease
  • Diabetes,
  • Incontinence
  • Infertility,
  • Liver Failure
  • Lung Disease
  • Multiple Sclerosis
  • Orthopedics
  • Osteoporosis
  • Parkinson' s Disease
  • Sickle Cell Disease
• Most Likely Case
  • Forecasts By Disease Area
  • Alzheimer' s Disease
  • Arthritis
  • Burns
  • Cancer,
  • Cardiovascular Conditions
  • Critical Limb Ischemia
  • Crohn' s Disease
  • Diabetes,
  • Incontinence
  • Infertility,
  • Liver Failure
  • Lung Disease
  • Multiple Sclerosis
  • Orthopedics
  • Osteoporosis
  • Parkinson' s Disease
  • Sickle Cell Disease

CHAPTER FIVE: COMPANY PROFILES

• Aastrom Biosciences
• Advanced Cell Technologies
• Athersys
• Brainstorm Cell Therapeutics
• Celegene
• ES Cell International
• Medistem
• MultiCell Technologies, Inc.
• Neostem
• Nephros Therapeutics, Inc.
• Opexa Therapeutics
• Osiris Therapeutics
• Plureon
• Regenetech
• Revivicor
• Stem Cell Sciences
• ThermoGenesis
• VetCell Bioscience

LIST OF EXHIBITS

CHAPTER ONE: EXECUTIVE SUMMARY

• Table 1-2: Stem Cell Therapeutics Market in $ Millions, 2007-2020

CHAPTER TWO: CURRENT STEM CELL THERAPIES

• Table 2-1: Types of Leukemia, 2007

CHAPTER THREE: DEVELOPMENTAL STEM CELL THERAPIES

• Table 3-1: Global Disease Populations Addressed by Potential Stem Cell Therapies, 2007
• Table 3-2: Estimated and Projected World Cancer Incidence by Selected Types of Cancer, 2007 and 2020
• Table 3-3: Estimated and Projected World Cancer Mortality by Selected Types of Cancer, 2007 and 2020
• Table 3-4: Types and Features of Urinary Incontinence, 2007
• Table 3-5: Types and Causes of Male Infertility, 2007
• Table 3-6: Common Diseases of the Lungs, 2007

CHAPTER FOUR: STEM CELL MARKET FORECASTS

• Table 4-1: Persons Affected by Key Stem Cell Therapeutic Targets in Millions, 2007
• Table 4-2: Best Case: Procedure Volume for Proprietary Stem Cell Therapies by Disease in Millions, 2007 - 2020(Alzheimer' s Disease, Arthritis, Burns, Cancer, Cardiovascular Conditions, Critical Limb Ischemia, Crohn' s Disease, Diabetes, Incontinence, Infertility, Liver Failure, Lung Disease, Multiple Sclerosis, Orthopedics, Osteoporosis, Parkinson' s Disease, Sickle Cell Disease)
• Table 4-3: Best Case: Revenues for Proprietary Stem Cell Therapies by Disease in $ Millions, 2007 - 2020(Alzheimer' s Disease, Arthritis, Burns, Cancer, Cardiovascular Conditions, Critical Limb Ischemia, Crohn' s Disease, Diabetes, Incontinence, Infertility, Liver Failure, Lung Disease, Multiple Sclerosis, Orthopedics, Osteoporosis, Parkinson' s Disease, Sickle Cell Disease)
• Table 4-4: Most Likely Case: Procedure Volume for Proprietary Stem Cell Therapies by Disease in Millions, 2007 - 2020(Alzheimer' s Disease, Arthritis, Burns, Cancer, Cardiovascular Conditions, Critical Limb Ischemia, Crohn' s Disease, Diabetes, Incontinence, Infertility, Liver Failure, Lung Disease, Multiple Sclerosis, Orthopedics, Osteoporosis, Parkinson' s Disease, Sickle Cell Disease)
• Table 4-5: Most Likely Case: Revenues for Proprietary Stem Cell Therapies by Disease in $ Millions, 2007-2020(Alzheimer' s Disease, Arthritis, Burns, Cancer, Cardiovascular Conditions, Critical Limb Ischemia, Crohn' s Disease, Diabetes, Incontinence, Infertility, Liver Failure, Lung Disease, Multiple Sclerosis, Orthopedics, Osteoporosis, Parkinson' s Disease, Sickle Cell Disease)

CHAPTER FIVE: COMPANY PROFILES

• Table 5-1: Therapeutic Focus of Selected Stem Cell Therapeutics Companies, 2007